Pfizer Gets CDSCO Panel Nod To study Marstacimab Dr. Divya Colin4 April 2025 6:00 PM ISTNew Delhi: The pharmaceutical major Pfizer has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Intas Pharmaceutical Gets CDSCO Panel Nod to study Vedolizumab Powder for Concentrate for Solution for Infusion Dr. Divya Colin9 Feb 2025 5:30 PM ISTNew Delhi: Intas Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Syngene International Gets CDSCO Panel Nod To study Trinbelimab Injection Dr. Divya Colin15 Aug 2023 5:00 PM ISTNew Delhi: Based on the Phase I clinical trial protocol presented by the drug major Synegene International to evaluate the pharmacokinetics and...
Lancet: Covaxin has tolerable safety, enhanced immunity in phase 1 trials Dr. Kamal Kant Kohli23 Jan 2021 11:00 AM ISTIt's a good news that Covaxin has become the first Covid-19 vaccine from India to have its data published in Lancet endorsing that the vaccine...
